THC-Free CBD Isolate: Sourcing Guide for European Buyers

THC-Free CBD Isolate: Sourcing Guide for European Buyers

Category: Sourcing Guide | Published: April 2026 | Read Time: 11 min

European demand for pharmaceutical- and nutraceutical-grade CBD isolate has grown substantially since the European Commission confirmed CBD's status as a Novel Food under Regulation (EU) 2015/2283. For procurement teams, formulators, and regulatory affairs managers sourcing CBD isolate at scale, the European market presents a specific and non-trivial compliance landscape — one where supplier qualification goes well beyond a purity figure on a certificate of analysis.

This guide covers the full sourcing decision: regulatory framework, quality benchmarks, supplier evaluation criteria, import logistics, and the questions that separate compliant, audit-ready suppliers from those that create downstream liability.

The EU Regulatory Framework for CBD Isolate

Novel Food Status and What It Means for B2B Buyers

The European Food Safety Authority (EFSA) confirmed in its 2022 guidance that CBD and CBD-containing extracts derived from Cannabis sativa L. fall within the scope of Regulation (EU) 2015/2283 on novel foods. This has two direct consequences for B2B buyers:

1. Finished product manufacturers placing CBD-containing food supplements or functional foods on the EU market must hold or be covered by a valid Novel Food authorisation.
2. Ingredient suppliers — including CBD isolate manufacturers — are not themselves required to hold Novel Food authorisation, but their product documentation must be sufficient to support their customers' authorisation applications and ongoing compliance obligations.

In practice, this means a CBD isolate supplier selling into the EU must be able to provide: full compositional data, process descriptions, stability data, and batch-level traceability documentation consistent with EFSA's dossier requirements. Suppliers who cannot provide this documentation create a compliance gap that falls on the buyer.

General Food Law: Traceability Under Regulation (EC) No 178/2002

Regulation (EC) No 178/2002 — the General Food Law — establishes the foundational traceability requirement for all food ingredients placed on the EU market: one step back, one step forward traceability at minimum, with documentation sufficient to enable rapid withdrawal in the event of a safety issue.

For CBD isolate, this means your supplier must maintain:

• Batch-level records linking isolate to source biomass lot
• Supplier qualification records for hemp biomass inputs
• Documented chain of custody from extraction through final packaging

Buyers who treat CBD isolate as a commodity ingredient and skip traceability verification are accepting regulatory risk that can materialize quickly during an EFSA inquiry or national competent authority audit.

THC Limits: The Critical Compliance Parameter

The EU sets a maximum THC content of 0.2% (by dry weight) in hemp plants at harvest under Regulation (EU) No 1307/2013. However, this farm-gate limit does not translate directly to finished isolate specifications.

For CBD isolate intended for food supplement or pharmaceutical applications, the operative standard is more stringent: THC non-detect (ND) by GC-MS analysis. This is not a regulatory threshold — it is a market reality. Major EU distributors, contract manufacturers, and pharmaceutical customers universally require THC ND on isolate COAs, and several national competent authorities (notably in Germany, France, and the Netherlands) apply zero-tolerance interpretations in practice.

Any supplier quoting a THC limit of "below 0.2%" for finished isolate is applying the wrong specification. The correct specification for EU-market CBD isolate is THC ND by validated GC-MS methodology, with a limit of quantification (LOQ) typically at or below 10 ppm.

Quality Benchmarks for EU-Grade CBD Isolate

Purity and Identity

Pharmaceutical- and nutraceutical-grade CBD isolate for the EU market should meet the following minimum specifications:

• CBD purity: ≥99.5% by HPLC
• CAS number: 13956-29-1 (cannabidiol)
• THC content: Non-detect (ND) by GC-MS, LOQ ≤10 ppm
• Total cannabinoids: ≥99.5% (CBD as primary cannabinoid)
• Residual solvents: Within ICH Q3C Class 3 limits (or ND for CO₂-extracted product)
• Heavy metals: Compliant with EU maximum limits (Pb <3 ppm, Cd <1 ppm, As <1 ppm, Hg <0.1 ppm per EC No 1881/2006 and relevant pharmacopoeial standards)
• Pesticide residues: ND or within EU MRL limits per Regulation (EC) No 396/2005
• Microbial limits: Total aerobic count <1,000 CFU/g, yeast and mould <100 CFU/g, Salmonella absent/25g, E. coli absent/1g
• Appearance: White to off-white crystalline powder
• Water content: ≤0.5% by Karl Fischer titration

Testing Methodology

COAs should specify the analytical method for each parameter — not just the result. For THC quantification, GC-MS with an authenticated reference standard is the accepted methodology. HPLC-UV or HPLC-DAD is standard for cannabinoid purity profiling. Buyers should be cautious of COAs that list results without method references, or that use immunoassay (lateral flow) methods for THC — these are screening tools, not confirmatory analytical methods.

Third-party testing by an ISO/IEC 17025-accredited laboratory is the minimum standard for EU market documentation. Supplier in-house testing data can supplement but should not replace accredited third-party COAs.

Supplier Evaluation Checklist

The following table provides a structured framework for qualifying CBD isolate suppliers for EU market supply. Use this during initial supplier assessment and annual re-qualification audits.

Import Logistics for European Buyers

Shipping Terms: DDP, CIF, and FOB

Understanding Incoterms is essential when importing CBD isolate from non-EU manufacturers. The three most common terms in this trade:

DDP (Delivered Duty Paid) — The supplier assumes all responsibility for export clearance, international freight, EU customs clearance, and import duties. This is the lowest-friction option for buyers new to direct import, but it typically carries a price premium and limits the buyer's visibility into logistics costs.

CIF (Cost, Insurance, and Freight) — The supplier covers freight and insurance to the named EU port of destination. The buyer handles EU customs clearance and import duties. This is a common middle-ground arrangement that gives buyers more control over the final leg while keeping upstream logistics with the supplier.

FOB (Free On Board) — The supplier's responsibility ends when goods are loaded onto the vessel at the origin port. The buyer assumes all freight, insurance, and import costs from that point. FOB is preferred by buyers with established freight forwarding relationships and those managing multi-origin supply chains.

For CBD isolate specifically, DDP and CIF are most common in initial supplier relationships. As volumes scale and logistics relationships mature, many buyers transition to FOB to optimise total landed cost.

Customs Classification and Import Documentation

CBD isolate typically imports under CN code 2932.99 (other heterocyclic compounds with oxygen heteroatom(s) only) or 1302.19 (vegetable saps and extracts), depending on the form and the member state customs authority's interpretation. Classification can vary — buyers should confirm the applicable CN code with their customs broker before the first shipment.

Required import documentation typically includes:

• Commercial invoice with full product description, CAS number (13956-29-1), and HS/CN code
• Certificate of Analysis (batch-specific, third-party)
• Certificate of Origin
• Phytosanitary certificate (required by some member states)
• Safety Data Sheet (SDS)
• For pharmaceutical-grade material: additional GMP documentation may be required by national competent authorities

Some EU member states — notably Germany and France — may require additional documentation or pre-notification for CBD ingredient imports. Engaging a customs broker with specific experience in botanical extract imports is strongly recommended.

Packaging and Labelling for EU Import

CBD isolate for B2B import should be packaged in food-grade, hermetically sealed containers (typically aluminium foil bags or HDPE drums with moisture barrier liners) with nitrogen flush to prevent oxidation. Labelling must include: product name, CAS number, batch number, net weight, manufacturing date, expiry date, storage conditions, and supplier contact information. For pharmaceutical-grade material, GMP labelling requirements apply.

Working with Vetrux: What EU Buyers Should Know

Vetrux CBD manufactures CBD isolate (CAS 13956-29-1) at ≥99.5% purity using supercritical CO₂ extraction from certified hemp biomass. All production batches are tested for THC by GC-MS (result: ND), with third-party COAs from ISO/IEC 17025-accredited laboratories provided as standard.

Our quality system operates under ISO 9001:2015 and HACCP frameworks, with GMP-aligned manufacturing practices. We maintain full batch traceability from biomass sourcing through final isolate packaging, and our technical team can provide compositional data and process documentation in formats compatible with EFSA Novel Food dossier requirements.

For EU buyers, Vetrux offers DDP, CIF, and FOB shipping terms with standard lead times of 10–14 business days from order confirmation. Sample quantities (100g–1kg) are available for qualification testing prior to commercial orders.

Frequently Asked Questions

Q: Is CBD isolate legal to import into all EU member states?

The legal status of CBD as a food ingredient varies in interpretation across EU member states, though the Novel Food framework under Regulation (EU) 2015/2283 provides the overarching EU-level structure. Most member states permit the import and sale of CBD isolate as a food ingredient or supplement ingredient, provided it is covered by a valid Novel Food authorisation or is being used in a product category not subject to Novel Food rules (e.g., cosmetics, which are regulated under Regulation (EC) No 1223/2009). Germany, the Netherlands, and the UK (post-Brexit, under UK Novel Food rules) are among the most active markets with established regulatory pathways. Buyers should conduct country-specific legal review before market entry, particularly for France and certain Central/Eastern European markets where national interpretations remain more restrictive.

Q: What is the difference between "THC-free" and "THC ND" on a COA?

"THC-free" is a marketing term with no standardised analytical definition. "THC ND" (non-detect) is an analytical result meaning THC was not detected above the method's limit of quantification (LOQ). The distinction matters because a product labelled "THC-free" may have been tested with a method that has a high LOQ — meaning low but non-zero THC levels could be present and simply not detected. For EU compliance purposes, always request the specific analytical method, the LOQ, and the instrument used (GC-MS is the accepted standard). A COA stating "THC ND by GC-MS, LOQ 10 ppm" is a meaningful, verifiable specification. "THC-free" without method details is not.

Q: What documentation do I need from my CBD isolate supplier to support an EFSA Novel Food application?

EFSA's Novel Food dossier requirements for CBD-containing products are detailed in the Authority's guidance document on applications under Regulation (EU) 2015/2283. For the ingredient specification section, you will typically need: full compositional analysis (cannabinoid profile, contaminant data), manufacturing process description, batch-to-batch consistency data (minimum 3 commercial-scale batches), stability data under ICH Q1A conditions, and specification limits with analytical methods. Your supplier should be able to provide all of this as part of their standard technical documentation package. If a supplier cannot provide process descriptions or multi-batch consistency data, this is a significant qualification red flag — not just for the dossier, but for supply chain reliability generally.

Conclusion

Sourcing THC-free CBD isolate for the European market is a compliance-intensive process that rewards buyers who treat supplier qualification as a structured, documentation-driven exercise rather than a price comparison. The regulatory framework — Novel Food under EU 2015/2283, General Food Law traceability under Regulation (EC) No 178/2002, and the practical THC ND standard enforced by EU customers and competent authorities — creates a clear set of requirements that qualified suppliers should meet without exception.

The supplier evaluation checklist in this guide provides a practical starting point. Prioritise third-party COA documentation, GMP/HACCP/ISO 9001 certification, full batch traceability, and confirmed THC ND by GC-MS. Verify shipping terms and import documentation requirements before committing to a supply relationship, and ensure your supplier can support your regulatory documentation needs as your EU market position develops.

If you are ready to qualify a supplier or request samples and technical documentation, submit an inquiry and our team will respond within one business day.

Vetrux CBD supplies pharmaceutical- and nutraceutical-grade CBD isolate (CAS 13956-29-1, ≥99.5% purity, THC ND by GC-MS) to B2B customers in Europe and globally. Technical documentation, sample requests, and pricing inquiries are handled directly by our export team.